menu
    • menu

    Company profile for Galecto

    NEW Drugs in Dev: 7
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Galecto develops small molecules for the treatment of severe diseases, including fibrosis, cancer and inflammation– for more information see: Products. The company builds on more than 10 years of research for treatment of fibrosis and cancer, as well as the role of galectins in disease and the use of galectin modulators to treat disease. Combined with a strong patent estate, these assets give Galecto a unique therapeutic ...
    Galecto develops small molecules for the treatment of severe diseases, including fibrosis, cancer and inflammation– for more information see: Products. The company builds on more than 10 years of research for treatment of fibrosis and cancer, as well as the role of galectins in disease and the use of galectin modulators to treat disease. Combined with a strong patent estate, these assets give Galecto a unique therapeutic platform. Galecto was founded in 2011 by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark. The company today is located in Copenhagen, Denmark.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GalectoDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Ole Maaloes Vej 3 Cobis Science Park Copenhagen, DK-2200,
    Telephone
    Telephone
    (+45) 70 70 52 10
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://galecto.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/galecto-biotech/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/GalectoBiotech

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Galecto To Join Leerink Partners Global Healthcare Conference
    Galecto To Join Leerink Partners Global Healthcare Conference

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247333/0/en/Galecto-to-Participate-in-Leerink-Partners-2026-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    Galecto Completes Public Offering, Raises $316.3M
    Galecto Completes Public Offering, Raises $316.3M

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237641/0/en/Galecto-Announces-Closing-of-Public-Offering-and-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares-for-Gross-Proceeds-of-316-3-Million.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Galecto Announces Public Offering of Common and Preferred Stock
    Galecto Announces Public Offering of Common and Preferred Stock

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235779/0/en/Galecto-Announces-Proposed-Underwritten-Public-Offering-of-Common-Stock-and-Preferred-Stock.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Galecto Emphasizes Strategic Goals And 2026 Milestones
    Galecto Emphasizes Strategic Goals And 2026 Milestones

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216823/0/en/Galecto-Highlights-Key-Strategic-Priorities-and-Anticipated-2026-Milestones.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Galecto Announces Key Additions To Leadership Team
    Galecto Announces Key Additions To Leadership Team

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213548/0/en/Galecto-Announces-Key-Additions-to-Leadership-Team.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Galecto Awards Inducement Equity Grant Under Nasdaq Rule
    Galecto Awards Inducement Equity Grant Under Nasdaq Rule

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206642/0/en/Galecto-Inc-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search